HALOTHANE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for halothane and what is the scope of patent protection?
Halothane
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, BH, Halocarbon, and Hospira, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for halothane.
Summary for HALOTHANE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 11 |
| Patent Applications: | 6,949 |
| DailyMed Link: | HALOTHANE at DailyMed |
Recent Clinical Trials for HALOTHANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 1/Phase 2 |
| Marian Hajduch, M.D., Ph.D. | Phase 2 |
| University Hospital Olomouc | Phase 2 |
Medical Subject Heading (MeSH) Categories for HALOTHANE
Anatomical Therapeutic Chemical (ATC) Classes for HALOTHANE
US Patents and Regulatory Information for HALOTHANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | HALOTHANE | halothane | LIQUID;INHALATION | 083254-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bh | HALOTHANE | halothane | LIQUID;INHALATION | 084977-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Halocarbon | HALOTHANE | halothane | LIQUID;INHALATION | 080810-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | FLUOTHANE | halothane | LIQUID;INHALATION | 011338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
